Protein energy malnutrition differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 241: Line 241:
* [[Body water|Total body water]] and [[fat]]
* [[Body water|Total body water]] and [[fat]]
* Sequential [[anthropometry]] (mid arm circumference, [[triceps]], skinfold thickness) to predict prognosis
* Sequential [[anthropometry]] (mid arm circumference, [[triceps]], skinfold thickness) to predict prognosis
| style="background: #DCDCDC; padding: 5px;" | Prognosis is good with the use of HAART  
| style="background: #DCDCDC; padding: 5px;" | Prognosis is good with the use of [[AIDS antiretroviral drugs|HAART]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* HAART
* [[AIDS antiretroviral drugs|HAART]]
* Megestrol acetate
* [[Megestrol acetate]]
* Marijuana (in some states)
* [[Marijuana]] (in some states)
* Dronabinol
* [[Dronabinol]]
* Somatropin
* [[Somatropin]]
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | Congenital heart disease
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Chronic pancreatitis]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''Chronic pancreatitis'''
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Tumors or stones
* [[Tumors]] or [[Kidney stone|stones]]
* Toxic metabolites  
* [[Metabolites|Toxic metabolites]]
* Necrosis
* [[Necrosis]]
* Fibrosis
* [[Fibrosis]]
* Oxidative stress
* [[Oxidative stress]]
* Ischemia
* [[Ischemia]]
* Alcohol consumption
* [[Alcohol consumption]]
* Autoimmune disorders
* [[Autoimmune disorders]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* 30 to 40 years
* 30 to 40 years
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Epigastric abdominal pain
* [[Epigastric pain|Epigastric abdominal pain]]
* Nausea
* [[Nausea]]
* Vomiting
* [[Vomiting]]
* Decreased appetite
* [[Decreased appetite]]
* Exocrine and endocrine dysfunction
* [[Exocrine]] and [[Endocrine disease|endocrine dysfunction]]
* Weight loss
* [[Weight loss]]
* Protein deficiency
* [[Protein deficiency]]
* Diarrhea and steatorrhoea
* [[Diarrhea]] and [[steatorrhoea]]
* Secondary diabetes mellitus
* Secondary [[diabetes mellitus]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Avoiding alcohol can reduce the risk for the development of chronic pancreatitis.
* Avoiding [[alcohol]] can reduce the risk for the development of [[chronic pancreatitis]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Pancreatic enzymes
* [[Pancreatic]] [[enzymes]]
* Blood sugar
* [[Blood sugar]]
* Stool analysis for presence of enzymes and fat
* [[Stool examination|Stool analysis]] for presence of [[enzymes]] and [[fat]]
* Computerized tomography
* [[Computed tomography|Computerized tomography]]
* X-rays
* [[X-rays]]
* Magnetic resonance cholangiopancreatography
* [[Magnetic resonance cholangiopancreatography]]
* Transabdominal ultrasound
* [[Ultrasonic Imaging|Transabdominal ultrasound]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Patients who get medical care early have a good prognosis
* Patients who get medical care early have a good prognosis
* increased risk of pancreatic cancer
* Increased risk of [[pancreatic cancer]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Ibuprofen and acetaminophen along with antioxidants
* [[Ibuprofen]] and [[acetaminophen]] along with [[antioxidants]]
* Surgical options are considered if medical options fail
* [[Surgery operation|Surgical options]] are considered if [[Medical therapy template|medical options]] fail
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''Pediatric nephrotic syndrome'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Nephrotic syndrome|Pediatric nephrotic syndrome]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Glomerular lesions such as minimal change nephrotic syndrome
* [[Glomerular disease|Glomerular lesions]] such as [[Minimal change GN|minimal change nephrotic syndrome]]
* Secondary nephrotic syndromes
* Secondary [[Nephrotic syndrome|nephrotic syndromes]]
* Genetic abnormalities such as infantile nenphrotic syndromes
* [[Genetics|Genetic abnormalities]] such as [[Nephrotic syndromes|infantile nephrotic syndromes]]
* Infections
* [[Infections]]
* Drugs
* [[Drugs]]
| style="background: #F5F5F5; padding: 5px;" | <16years
| style="background: #F5F5F5; padding: 5px;" | <16years
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Revision as of 12:56, 14 August 2017

Protein energy malnutrition Microchapters

Home

Patient Information

Kwashiorkor
Marasmus

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Protein energy malnutrition from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Protein energy malnutrition differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Protein energy malnutrition differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Protein energy malnutrition differential diagnosis

CDC on Protein energy malnutrition differential diagnosis

Protein energy malnutrition differential diagnosis in the news

Blogs on Protein energy malnutrition differential diagnosis

Kwashiorkor

Risk calculators and risk factors for Protein energy malnutrition differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

Protein energy malnutrition must be differentiated from other diseases that cause failure to thrive, edema, wasting recurrent infections, skin and hair changes. It is important to also differentiate kwashiorkor from marasmus as the two diseases belong to the protein energy malnutrition.

Differentiating Protein energy malnutrition from other Diseases

Differentiating kwashiorkor from marasmus[1]

Distinguishing Features Kwashiorkor Marasmus
Cause Deficiency of protein in the diet of child Deficiency of protein as well as energy nutrients (that is carbohydrates and fats) in the diet
Age Occurs in children in the age group 1-5 years Typically occurs in children below the age of 1 year
Association More common in villages where there is small gap period between successive pregnancies More common in towns and cities where breast-feeding in discontinued quite early
Edema Presence of edema Absence of edema
Muscles Wasting of muscles Wasting of muscles is quite evident. The child is reduced to skin and bones
Skin changes Dermatitis and Hyperpigmentation noticed Dry and atrophic skin but no changes in color
Serum cortisol Decreased/Normal Increased
Fasting blood glucose Decreased Decreased
Growth retardation Mildly retarded in growth Severely retarded in growth
Facial appearance Moon-like face Elderly man face
Abdomen Protuded Shrunken
Vitamin deficiency Present Present
Weight 60-80% of normal weight for age <60% of normal weight for age

Differential diagnosis of edema and wasting [2][3][4][5][6][7][8][9]

Disease Cause Age(years) Presentation Prevention Workup Prognosis Treatment
Kwashiorkor
  • < 1
Marasmus
  • < 5
: :
Protein losing enteropathy
  • All age groups
  • Prognosis largely depends on the underlying disease
  • If it is potentially curable, prognosis improves considerably
Anasarca 1-4 Good prognosis if the underlying cause is identified and treated early
HIV wasting syndrome HIV infection
  • All age groups
Prognosis is good with the use of HAART
Chronic pancreatitis
  • 30 to 40 years
  • Patients who get medical care early have a good prognosis
  • Increased risk of pancreatic cancer
Pediatric nephrotic syndrome <16years
  • Nephrotic-range proteinuria
  • Edema
  • Hyperlipidemia,
  • Hypoalbuminemia
  • Avoid infections and drugs that may predispose to nephrotic syndrome
  • Urinalysis
  • Urine protein quantification (by first-morning urine protein/creatinine or 24-hour urine protein)
  • Serum albumin
  • Lipid panel
  • Prognosis depends on whether the nephrotic syndrome is steroid responsive or steroid resistant
  • Corticosteroids
  • Diuretics
  • Antihypertensive agents
  • Alkylating agents
  • Calcineurin inhibitors
  • Home monitoring of urine protein and fluid status
Portal cirrhosis
  • Hepatitis C (26%)
  • Alcoholic liver disease (21%)
  • Hepatitis C plus alcoholic liver disease (15%)
  • Cryptogenic causes (18%) - Many cases actually are due to NAFLD
  • Hepatitis B - May be coincident with hepatitis D (15%)
  • Miscellaneous (5%)
5th - 6th decade of life
  • Hepatomegaly
  • Abdominal pain
  • Ascites
  • Abdominal distension
  • Bulging flanks
  • Shifting dullness
  • Puddle sign
  • Avoid alcohol
  • Treatment and vaccination against hepatitis
  • Good diet and exercise
  • CBC
  • Albumin
  • Culture
  • Total protein
  • Serum ascites albumin gradient
  • Ammonia level
Prognosis is poor
  • Prednisone and azathioprine - For autoimmune hepatitis
  • Interferon and other antiviral agents - For hepatitis B and C
  • Phlebotomy - For hemochromatosis
  • Ursodeoxycholic acid - For primary biliary cirrhosis
  • Trientine and zinc - For Wilson disease
  • Liver transplantation

Table adapted from CDC Pinkbook.[10]

References

  1. Müller O, Krawinkel M (2005). "Malnutrition and health in developing countries". CMAJ. 173 (3): 279–86. doi:10.1503/cmaj.050342. PMC 1180662. PMID 16076825.
  2. Cho EJ, Kim MY, Lee JH, Lee IY, Lim YL, Choi DH; et al. (2015). "Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis". PLoS One. 10 (7): e0133935. doi:10.1371/journal.pone.0133935. PMC 4511411. PMID 26196942.
  3. Cuzzoni E, De Iudicibus S, Franca R, Stocco G, Lucafò M, Pelin M; et al. (2015). "Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome". Pharmacogenomics. 16 (14): 1631–48. doi:10.2217/pgs.15.101. PMID 26419298.
  4. DiMagno MJ, DiMagno EP (2013). "Chronic pancreatitis". Curr Opin Gastroenterol. 29 (5): 531–6. doi:10.1097/MOG.0b013e3283639370. PMC 4387887. PMID 23852141.
  5. Keithley JK, Swanson B (2013). "HIV-associated wasting". J Assoc Nurses AIDS Care. 24 (1 Suppl): S103–11. doi:10.1016/j.jana.2012.06.013. PMID 23290370.
  6. Nahlen BL, Chu SY, Nwanyanwu OC, Berkelman RL, Martinez SA, Rullan JV (1993). "HIV wasting syndrome in the United States". AIDS. 7 (2): 183–8. PMID 8466680.
  7. Vogelaar JL, Loar RW, Bram RJ, Fischer PR, Kaushik R (2014). "Anasarca, hypoalbuminemia, and anemia: what is the correlation?". Clin Pediatr (Phila). 53 (7): 710–2. doi:10.1177/0009922814526990. PMID 24647692.
  8. Amiot A (2015). "[Protein-losing enteropathy]". Rev Med Interne. 36 (7): 467–73. doi:10.1016/j.revmed.2014.12.001. PMID 25618488.
  9. Ramírez Prada D, Delgado G, Hidalgo Patiño CA, Pérez-Navero J, Gil Campos M (2011). "Using of WHO guidelines for the management of severe malnutrition to cases of marasmus and kwashiorkor in a Colombia children's hospital". Nutr Hosp. 26 (5): 977–83. doi:10.1590/S0212-16112011000500009. PMID 22072341.
  10. "Epidemiology and Prevention of Vaccine-Preventable Diseases".

Template:WH Template:WS